Clearmind Medicine Inc. (CMND)
1.35
-0.02 (-1.46%)
At close: Jan 30, 2025, 11:41 AM
undefined% (undefined)
| Bid | 1.35 |
| Market Cap | 5.92M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -0.8 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.36 |
| Volume | 9,246 |
| Avg. Volume (20D) | 1,041,760 |
| Open | 1.36 |
| Previous Close | 1.37 |
| Day's Range | 1.35 - 1.39 |
| 52-Week Range | 0.95 - 2.30 |
| Beta | undefined |
About CMND
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March ...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 15, 2022
Employees 4
Stock Exchange NASDAQ
Ticker Symbol CMND
3 weeks ago
+6.04%
SciSparc and Clearmind Medicine shares are trading...
Unlock content with
Pro Subscription
4 weeks ago
+5.07%
Clearmind Medicine shares are trading higher after the company was granted a patent by the Macau International Intellectual Property Office for binge behavior treatment.
